Lipid-based nanocarrier-enabled combination therapy for breast cancer: overcoming drug resistance toward precision oncology.
This paper presents a comprehensive review of recent advances in lipid-based nanocarrier-mediated combination therapies in breast cancer treatment, highlighting the need for developing more effective and specific strategies to address the mentioned obstacles.